Preferred Label : Refsum disease, classic;
CISMeF acronym : HMSN4;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Phytanic acid oxidase deficiency; Hereditary motor and sensory neuropathy iv; Refsum disease, adult, 1; Hmsn iv; Heredopathia atactica polyneuritiformis; HMSN4;
Description : Refsum disease is an autosomal recessive inborn error of lipid metabolism classically
characterized by a tetrad of clinical abnormalities: retinitis pigmentosa, peripheral
neuropathy, cerebellar ataxia, and elevated protein levels in the cerebrospinal fluid
(CSF) without an increase in the number of cells. However, not all patients show all
these features. All patients have accumulation of an unusual branched-chain fatty
acid, phytanic acid, in blood and tissues. Other variable features include cardiac
dysfunction, nerve deafness, ichthyosis, and multiple epiphyseal dysplasia (review
by Skjeldal et al., 1987). Increased levels of phytanic acid can also be found in
peroxisomal biogenesis disorders; see Zellweger syndrome (see 214100) (Skjeldal et
al., 1987). Infantile Refsum disease (see PBD1B, 601539) is a distinct disorder with
a different phenotype and genetic basis. A phenotype clinically indistinguishable
from that of classic Refsum disease (PBD9B; 614879), but with a different biochemical
profile, can be caused by mutation in the gene encoding peroxin-7 (PEX7; 601757) on
chromosome 6q.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the phytanoyl-CoA hydroxylase gene (PHYH, 602026.0001); Caused by mutation in the peroxisome biogenesis factor 7 gene (PEX7, 601757.0007);
Laboratory abnormalities : Increased phytanic acid in body tissues and fluids; Decreased phytanic acid oxidase activity;
Prefixed ID : #266500;
Origin ID : 266500;
UMLS CUI : C0034960;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)